
Amicus Therapeutics, Vertex Pharmaceuticals, and Danaher are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of companies that develop medicines, therapies, diagnostics, or other products using biological processes, molecular biology, and related life‑science technologies. For investors, these stocks tend to be research‑intensive and highly sensitive to clinical trial results, regulatory approvals, and scientific breakthroughs, which can lead to above‑average volatility and both large upside and downside risk. These companies had the highest dollar trading volume of any Biotech stocks within the last several days.
Amicus Therapeutics (FOLD)
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset.
Vertex Pharmaceuticals (VRTX)
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor.
Read Our Latest Research Report on VRTX
Danaher (DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read Our Latest Research Report on DHR
Featured Articles
- MarketBeat’s Top Five Stocks to Own in December 2025
- 2 Stocks to Avoid as Crypto Momentum Wanes
- 3 Dividend Growth Stocks Analysts Are Upgrading for 2026
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
